Carl Zeiss Meditec AG (AFX.DE)
EUR 58.8
(-0.76%)
EUR 58.8
(-0.76%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 155.69 Million EUR | 21.73% |
| 2022 | 127.9 Million EUR | 5.47% |
| 2021 | 121.27 Million EUR | 76.77% |
| 2020 | 68.6 Million EUR | 19.34% |
| 2019 | 57.48 Million EUR | 429.85% |
| 2018 | 10.85 Million EUR | 86.62% |
| 2017 | 5.81 Million EUR | -35.26% |
| 2016 | 8.98 Million EUR | -26.54% |
| 2015 | 12.22 Million EUR | -7.75% |
| 2014 | 13.25 Million EUR | -7.41% |
| 2013 | 14.31 Million EUR | -53.7% |
| 2012 | 30.9 Million EUR | 188.92% |
| 2011 | 10.69 Million EUR | -41.2% |
| 2010 | 18.19 Million EUR | -0.2% |
| 2009 | 18.23 Million EUR | -6.98% |
| 2008 | 19.59 Million EUR | -55.97% |
| 2007 | 44.51 Million EUR | 0.0% |
| 2006 | - EUR | 0.0% |
| 2005 | - EUR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | - EUR | -100.0% |
| 2024 Q2 | 142 Million EUR | 0.0% |
| 2024 Q3 | - EUR | -100.0% |
| 2023 Q3 | - EUR | -100.0% |
| 2023 Q1 | - EUR | -100.0% |
| 2023 Q2 | 211.3 Million EUR | 0.0% |
| 2023 Q4 | 155.69 Million EUR | 0.0% |
| 2023 FY | 155.69 Million EUR | 21.73% |
| 2022 FY | 127.9 Million EUR | 5.47% |
| 2022 Q4 | 127.9 Million EUR | 0.0% |
| 2022 Q3 | - EUR | -100.0% |
| 2022 Q2 | 120.04 Million EUR | 0.0% |
| 2022 Q1 | - EUR | -100.0% |
| 2021 FY | 121.27 Million EUR | 76.77% |
| 2021 Q2 | 119.89 Million EUR | 0.0% |
| 2021 Q3 | - EUR | -100.0% |
| 2021 Q4 | 121.27 Million EUR | 0.0% |
| 2021 Q1 | - EUR | -100.0% |
| 2020 Q4 | 68.6 Million EUR | 0.0% |
| 2020 Q3 | - EUR | -100.0% |
| 2020 FY | 68.6 Million EUR | 19.34% |
| 2020 Q1 | - EUR | -100.0% |
| 2020 Q2 | 53.51 Million EUR | 0.0% |
| 2019 Q3 | - EUR | -100.0% |
| 2019 Q4 | 57.48 Million EUR | 0.0% |
| 2019 Q1 | - EUR | -100.0% |
| 2019 FY | 57.48 Million EUR | 429.85% |
| 2019 Q2 | 60.41 Million EUR | 0.0% |
| 2018 Q1 | - EUR | -100.0% |
| 2018 Q3 | - EUR | -100.0% |
| 2018 Q4 | 10.85 Million EUR | 0.0% |
| 2018 FY | 10.85 Million EUR | 86.62% |
| 2018 Q2 | 4.23 Million EUR | 0.0% |
| 2017 Q2 | 7.88 Million EUR | 0.0% |
| 2017 Q3 | - EUR | -100.0% |
| 2017 FY | 5.81 Million EUR | -35.26% |
| 2017 Q1 | - EUR | -100.0% |
| 2017 Q4 | 5.81 Million EUR | 0.0% |
| 2016 Q2 | 10.39 Million EUR | -8.46% |
| 2016 FY | 8.98 Million EUR | -26.54% |
| 2016 Q1 | 11.35 Million EUR | -7.14% |
| 2016 Q4 | 8.98 Million EUR | -9.71% |
| 2016 Q3 | 9.94 Million EUR | -4.28% |
| 2015 Q2 | 13.99 Million EUR | 6.74% |
| 2015 Q4 | 12.22 Million EUR | -5.16% |
| 2015 FY | 12.22 Million EUR | -7.75% |
| 2015 Q3 | 12.88 Million EUR | -7.88% |
| 2015 Q1 | 13.1 Million EUR | -1.07% |
| 2014 Q2 | 13.09 Million EUR | -3.49% |
| 2014 Q4 | 13.25 Million EUR | 3.77% |
| 2014 FY | 13.25 Million EUR | -7.41% |
| 2014 Q1 | 13.56 Million EUR | -5.22% |
| 2014 Q3 | 12.76 Million EUR | -2.45% |
| 2013 Q3 | 15.12 Million EUR | -31.92% |
| 2013 Q4 | 14.31 Million EUR | -5.37% |
| 2013 FY | 14.31 Million EUR | -53.7% |
| 2013 Q1 | 21.87 Million EUR | -29.23% |
| 2013 Q2 | 22.21 Million EUR | 1.55% |
| 2012 Q4 | 30.9 Million EUR | 82.56% |
| 2012 Q2 | 16.43 Million EUR | -4.96% |
| 2012 Q3 | 16.93 Million EUR | 3.0% |
| 2012 FY | 30.9 Million EUR | 188.92% |
| 2012 Q1 | 17.29 Million EUR | 61.68% |
| 2011 Q1 | 18.2 Million EUR | 0.04% |
| 2011 FY | 10.69 Million EUR | -41.2% |
| 2011 Q4 | 10.69 Million EUR | -34.16% |
| 2011 Q3 | 16.24 Million EUR | -4.99% |
| 2011 Q2 | 17.1 Million EUR | -6.04% |
| 2010 Q4 | 18.19 Million EUR | -11.21% |
| 2010 FY | 18.19 Million EUR | -0.2% |
| 2010 Q3 | 20.49 Million EUR | 7.47% |
| 2010 Q1 | 18.27 Million EUR | 0.22% |
| 2010 Q2 | 19.06 Million EUR | 4.35% |
| 2009 FY | 18.23 Million EUR | -6.98% |
| 2009 Q4 | 18.23 Million EUR | 0.0% |
| 2008 FY | 19.59 Million EUR | -55.97% |
| 2007 FY | 44.51 Million EUR | 0.0% |
| 2006 FY | - EUR | 0.0% |
| 2005 FY | - EUR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| SCHOTT Pharma AG & Co. KGaA | 72.33 Million EUR | -115.255% |
| Fielmann Aktiengesellschaft | 652.37 Million EUR | 76.134% |
| Gerresheimer AG | 1.04 Billion EUR | 85.048% |
| Sartorius Aktiengesellschaft | 5.31 Billion EUR | 97.069% |
| Sartorius Aktiengesellschaft | 5.31 Billion EUR | 97.069% |